News

All team of IOCB Tech is proud that IOCB Prague has become one of the strategic institutes in the MediAim consortium, which brings together three centers of excellence in science, research, and clinical practice. Read more

Researchers from RCPTM and IOCB Tech have developed a new method for isolating viral RNA independent of commercially available materials. The production is being transferred to IOCB Tech, which will oversee distribution in the Czech Republic and Slovakia. Read more

In the next three years, IOCB Tech will provide 15 million Czech crowns (c. 550 thousand euros) in support of Neuron. Read more

IOCB Tech has donated 7 million Czech crowns (250 thousand euros) for research and development of new diagnostic tests for the infectious disease COVID-19. Read more

SHINE Medical Technologies LLC, IOCB Prague, and GE Healthcare today announced the production of patient dose quantities of the therapeutic isotope lutetium-177 (Lu-177). Read more

A prestigious new position is being established for a leading foreign expert in drug discovery and development at UCT Prague in collaboration with IOCB Prague. Read more

We are proud to announce that IOCB Tech is a co-organizer of the 6th year of the Prague-Weizmann Summer School on Drug Discovery 2019. Read more

SHINE Medical Technologies, Inc. and IOCB Prague have entered into an intellectual property license agreement providing SHINE with a global, exclusive license to a novel method for separating rare earth elements. Read more

Following four successful years of the Prague Summer School on Advances in Drug Discovery, this year the school will be held jointly with the Weizmann Institute of Science in Rehovot, Israel. Read more